To evaluate the effect of a smoking-, alcohol- or combined-cessation intervention starting shortly before surgery and lasting 6 weeks on overall complications after radical cystectomy. Secondary objectives are to examine the effect on types and grades of complications, smoking cessation and alcohol cessation, length of hospital stay, health-related quality of life and return to work or habitual level of activity up to 12 months postoperatively.
The study is a multi-institutional randomised clinical trial involving 110 patients with a risky alcohol intake and daily smoking who are scheduled for radical cystectomy. Patients will be randomised to the 6-week Gold Standard Programme (GSP) or treatment as usual (control). The GSP combines patient education and pharmacologic strategies. Smoking and alcohol intake is biochemically validated (blood, urine and breath tests) at the weekly meetings and at follow-up.
Herein, we report the design of the STOP-OP study, objectives and accrual up-date. This study will provide new knowledge about how to prevent smoking and alcohol-related postoperative complications at the time of bladder cancer surgery. Till now 77 patients have been enrolled. Patient accrual is expected to be finalised before the end of 2017 and data will be published in 2018.
ClinicalTrials.gov, ID: NCT02188446 . Registered on 28 May 2014.
Trials. 2017 Jul 17*** epublish ***
Susanne Vahr Lauridsen, Thordis Thomsen, Peter Thind, Hanne Tønnesen
Department of Urology, Copenhagen University Hospital, Rigshospitalet, 2112, Blegdamsvej 9, 2100, Copenhagen, Denmark. ., Abdominal Centre, Copenhagen University Hospital, Rigshospitalet and University of Copenhagen, Health and Medical Sciences, Copenhagen, Denmark., Department of Urology, Copenhagen University Hospital, Rigshospitalet, 2112, Blegdamsvej 9, 2100, Copenhagen, Denmark., Clinical Health Promotion Centre, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospitals, Copenhagen, Denmark.